Ternansky R J, Draheim S E
Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana 46285.
J Med Chem. 1993 Oct 29;36(22):3219-23. doi: 10.1021/jm00074a001.
The synthesis and biological evaluation of a series of pyrazolidinone-containing mono- and bicyclic compounds are described. The results of this investigation indicate that the [3.3.0] ring system bearing strongly electron-withdrawing groups in the 3-position provides the optimal arrangement for antibacterial activity. Two highly potent derivatives, LY193239 and LY255262, have been selected for further preclinical evaluation.